{"nct_id":"NCT00613730","title":"Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint","status":"TERMINATED","status_verified_date":"2013-11","start_date":"2007-01","start_date_type":null,"primary_completion_date":"2009-04","primary_completion_date_type":"ACTUAL","completion_date":"2009-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["AMGN"]}